NASDAQ:MYGN

Myriad Genetics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Diagnostics & Research

Open Broker Account

$19.47

-0.100 (-0.511%)

At Close: May 01, 2024

Currently predicting for Thu, 2 May 2024

Trading levels for MYGN

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	20.65	6.04 %
		R2	20.19	3.68 %
		R1	19.90	2.22 %
Current price:			19.47
	Support	S1	18.98	-2.51 %
		S2	18.70	-3.97 %
		S3	18.24	-6.33 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	23.50	20.70 %
		R2	21.16	8.68 %
		R1	19.80	1.69 %
Current price			19.47
	Support	S1	19.17	-1.54%
		S2	18.51	-4.93%
		S3	17.98	-7.65%

MYGN Predictions History

4 years ago
GoldenNugget predicted that MYGN for 2019-05-07 is going $34.64 (-1.04%)

4 years ago
NameNotImportant predicted that MYGN for 2019-05-06 is going $35.21 (2.53%)

4 years ago
GoldenNugget predicted that MYGN for 2019-05-06 is going $33.46 (-2.55%)

4 years ago
NameNotImportant predicted that MYGN for 2019-05-03 is going $31.82 (-7.34%)

6 years ago
JS predicted that MYGN for 2017-11-15 is going $31.08 (-0.54%)

About Myriad Genetics

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing... MYGN Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In